Last Updated: 19 Sep 2024
Executive Summary
Cosmos Health Inc. (COSM) is a vertically integrated pharmaceutical company headquartered in Chicago, Illinois. Despite its recent financial struggles, including negative EBITDA and EPS, the company has shown signs of improvement in its quarterly revenue growth. The stock price currently trades at $1.11, below its analyst target price of $4.
Company Overview
Cosmos Health Inc. operates in the real estate industry, focusing on real estate development and management. The company's portfolio includes various properties in the United States.
Fundamental Analysis
Revenue: COSM reported revenue of $56.45 million in the trailing twelve months (TTM), representing a 6.8% increase year-over-year.
Earnings: The company has incurred significant losses in recent quarters, with a diluted EPS of -$2.28 in the TTM.
Profitability: COSM's profit margins remain negative, with a gross profit margin of -38.2% and an operating margin of -19%.
Balance Sheet: The company has a book value of $1.81 per share and total debt of $19.9 million.
Technical Analysis
Price Action: COSM's stock price has been trending lower in recent months, trading within a range of $0.468 to $2.05 over the past year.
Moving Averages: The stock is currently trading below its 50-day and 200-day moving averages, indicating a bearish trend.
Support and Resistance: Key support levels lie at $0.468 and $1.00, while resistance levels exist at $2.05 and $4.00.
Short Term Outlook
In the short term, COSM's stock price is likely to remain volatile due to its weak fundamentals and negative earnings. The stock could face further downside pressure if the company fails to improve its financial performance.
Long Term Outlook
The long-term outlook for COSM is uncertain. If the company can turn around its financial performance and achieve profitability, the stock price could potentially rebound. However, the company's high debt levels and negative profit margins pose significant challenges.
Analyst Recommendations
Currently, there is only one analyst covering COSM, with a "Buy" rating and a target price of $4.00. This suggests that the analyst believes the stock has potential for upside in the long term.
